Taurus Oncology

Taveren Therapeutics

The company develops oncology drug candidates that reactivate natural tumour suppressors for pharmaceutical partners and cancer patients.

Avistone Pharmaceuticals

The company develops and manufactures precision oncology medicines, specifically small-molecule targeted therapies for patients with lung cancer and other solid tumours.

Orakl Oncology

This company develops a predictive platform using patient tumor avatars and data to help pharmaceutical firms accelerate and de-risk cancer drug development.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

Cumulus Oncology

This company develops preclinical oncology assets and creates spin-out biotechnology firms to advance cancer treatments for pharmaceutical partners and patients.

Crossfire Oncology

This company develops kinase-targeting inhibitors, degraders and degrader-antibody conjugates to treat cancer patients.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

Oncko

This company develops multi-drug cancer therapies and clinical platform trials to identify optimal treatment combinations and schedules for pharmaceutical partners and patients.